Generics 28

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Pirfenidone manufacturers

28 products found

Filters

28 products found

pirfenidone

Tablets 267 mg, 534 mg, 801 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Comments
Ref: Esbriet®
Manufacturer #252

Manufacturer usually replies in 2 days

pirfenidone

Capsules 267 mg, 534 mg, 801 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Available for
Licensing with supply, Technology transfer
Manufacturer #260
Pharmaceutical manufacturer operating in the EU for 50+ years. Activities include scientific development, manufacturing, out-licensing, marketing, and distribution of high-quality generic medicines. The company owns several production facilities that all comply with EU GMP requirements. Key dosage forms include conventional solids, cytostatic injectables, and cytostatic orals. The company holds an in-house R&D and Intellectual property business unit, as well as a regulatory affairs team that prepares CTD dossiers and maintains direct contact with regulatory agencies worldwide. The portfolio includes more than three thousand MA sets approved in the EU while hundreds of MA are in progress. Key therapy lines are cardiovascular, CNS, diabetes, immunology, oncology, and more. The company is active in nearly 100 countries worldwide, selling its products in Africa, Asia, Australia, Europe, LATAM, and the Middle East.

Manufacturer usually replies in 12 days

pirfenidone

Tablets 267 mg, 534 mg, 801 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam
Manufacturer #437
A pharmaceutical manufacturer based in the EU that is active in 40+ countries selling its products in Europe, North America, LATAM, Africa, Middle East, and Asia for 40+ years. Main therapeutics areas include the nervous system, cardiometabolic, and women’s health. The company's production lines are GMP-compliant. The main dosage forms are solid, semi-solid, liquid, and suspension. The company owns branches in the EU, Africa, and LATAM.

Manufacturer usually replies in 11 days

pirfenidone

Tablets, film coated 200 mg, 400 mg , 600 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
Turkey
GMP approvals
EU GMP
Unavailable markets
Bulgaria , Costa Rica
Registered in
Turkey
Manufacturer #361
It is a global player with more than half a century of experience. It has more than 4 facilities to operate from. They have marketing and promotion in more than 20 countries. It exports to more than 50 countries. The only motto is to improve the quality of human life and to provide access to reliable, high-quality products for human health worldwide. It is focused to create its own cadres in every country it operates.

Manufacturer usually replies in 9 days

pirfenidone

Capsules 267 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Manufacturer #15189
The company, which was founded in 1989, is involved in developing, manufacturing, and distributing a wide range of formulations for anti-infectives, cardiovascular, anti-diabetic, dermatological, and hormone treatment. The corporation has a global presence in 170 + countries, 60+ WHO-prequalified medications, and 3700+ product registrations.

Manufacturer usually replies in 9 days

pirfenidone

Tablets 267 mg, 801 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Unavailable markets
Costa Rica
Manufacturer #1338

Manufacturer usually replies in 7 days

pirfenidone

Tablets, film coated 267 mg, 534 mg , 801 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
India
GMP approvals
EU GMP
Unavailable markets
Chile , Panama
Available for
Licensing with supply
Manufacturer #261
A pharmaceutical manufacturer based in the EU that has been selling its products in Europe for 20+ years. Main therapeutic areas include diabetes, CNL, dermatology, and oncology. Main dosage forms include solid and liquid oral, sterile dosage forms, and ointments. The company possesses 10+ manufacturing facilities that are cGMP-compliant.

Manufacturer usually replies in 6 days

pirfenidone

Tablets, film coated 200 mg, 400 mg, 600 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Turkey
GMP approvals
EU GMP, Saudi Arabia, Ukraine
Unavailable markets
Canada , Costa Rica , Ukraine , Vietnam
Comments
Reference product is Pirespa 200mg (Japan) which is not registered in EU
Manufacturer #361
It is a global player with more than half a century of experience. It has more than 4 facilities to operate from. They have marketing and promotion in more than 20 countries. It exports to more than 50 countries. The only motto is to improve the quality of human life and to provide access to reliable, high-quality products for human health worldwide. It is focused to create its own cadres in every country it operates.

Manufacturer usually replies in 9 days

pirfenidone

Tablets 200 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19698

Manufacturer usually replies in 3 days

pirfenidone

Tablets 200MG

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18530

Manufacturer usually replies in 4 days

pirfenidone

Capsules 267MG.

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18530

Manufacturer usually replies in 4 days

pirfenidone

Tablets 200 mg, 400 mg, 600 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
South Korea
GMP approvals
PICS
Manufacturer #18096
Since its establishment in the 1950s, the company has been enjoying the privilege of playing a major role as a forerunner in the East Asian pharmaceutical industry for over half a century. Based on the long-term goal, they strive for further growth and expansion. A strong alliance with the worldwide pharmaceutical companies allows the company to expand the market worldwide and cope with the challenging environment of the global pharmaceutical industry. Through active involvement in R&D activities, quality management, and overseas business, they fulfill the expectations of customers and shareholders.

Manufacturer usually replies in 5 days

pirfenidone

Tablets, film coated 200mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
Argentina
Manufacturer #16247
The pharmaceutical company is currently in 120+ presentations corresponding to 50+ products that cover common clinical conditions, attended by a wide range of specialties. In Oncology and Special Treatments Line, which already has more than 3 products in more than 5 presentations, also venturing into the field of Pulmonology through a new Respiratory Line.

Manufacturer usually replies in 3 days

pirfenidone

Tablets 267 mg, 534 mg, 801 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
FDA, EU GMP
Unavailable markets
Iran , Vietnam
Available for
Licensing with supply
Comments
Indication: Idiopathic Pulmonary Fibrosis ; Status: MA granted
Manufacturer #385

A pharmaceutical manufacturer based in the EU that has been active in 60+ countries selling its products in Europe, North America, LATAM, MENA, Africa, and Asia for 60+ years. Key production lines are Rx and nutraceuticals. The company's production lines are EU GMP-compliant.

Manufacturer usually replies in 11 days

pirfenidone

Tablets, film coated 801 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
Turkey
GMP approvals
PICS
Manufacturer #13510
It was established in the 2010s. It creates and sells biotech products developed with natural product extracts, helping to improve your heart health, immune system, or mood. It offers the pharmaceutical and nutraceutical industry a natural, science-based therapeutic alternative that can be safely used either in combination with existing medications as add-on ingredients for improved efficacy or presented as a single standing remedy; with patented products, proven benefits, and claims for our natural ingredients in the areas of for example mood improvement, anxiety and stress reduction, eye-health, cardiovascular health advancement and enhancement of the body´s immune system against cold and flu.

Manufacturer usually replies in 6 days

pirfenidone

Tablets 200 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Available for
Licensing with supply, Distribution only, Technology transfer
Manufacturer #19588

Manufacturer usually replies in 7 days

pirfenidone

Tablets 200 mg, 400 mg, 600 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
South Korea
GMP approvals
South Korea
Manufacturer #20981
The company has a mission to relieve the suffering of mankind from diseases with our innovative, effective, and safe pharmaceutical products. They have received more than 20 awards including the President Award for Superior Product Development, the Prime Minister Award, Industry Award, and many more. These accomplishments demonstrate their sustainability and commitment to the development of innovative products and business excellence in both overseas and domestic segments.

Manufacturer usually replies in 7 days

pirfenidone

Tablets for oral solution 200 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19884

Manufacturer usually replies in 6 days

pirfenidone

Tablets 801 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
PICS
Manufacturer #16454
A pharmaceutical company based in South America with 15+ years of experience in a drug market. More than 40 products in 25+ countries: LATAM; Wester, Southern and South-eastern Asia. Company’s therapeutic areas consist of products that can used in such areas as: urology, oncology, rare diseases and more.

Manufacturer usually replies in 7 days

pirfenidone

Capsules 267 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
PICS
Manufacturer #16454
A pharmaceutical company based in South America with 15+ years of experience in a drug market. More than 40 products in 25+ countries: LATAM; Wester, Southern and South-eastern Asia. Company’s therapeutic areas consist of products that can used in such areas as: urology, oncology, rare diseases and more.

Manufacturer usually replies in 7 days

Want to view all 28 products? Create your free account today!

PIRFENIDONE manufacturers

Pirfenidone is a medication used to treat idiopathic pulmonary fibrosis ( chronic scarring lung disease characterized by a progressive and irreversible decline in lung function). Multiple companies around the world developed pirfenidone, and among them, the original patent holder Marnac, Inc. InterMune Inc., Shionogi Ltd., and GNI Group Ltd. Pirfenidone has been approved in different countries at different periods. Japan approved Pirfenidone medical use in 2008, 2010 in India, 2011 in Europe and China, 2012 in Canada, 2014 in the US and Mexico. Pirfenidone has many brand names, the most spread is Esbriet by Genentech, Inc in use in Europe, Canada, and the US, others are Pirespa by Shionogi, Pirfenex by Cipla, Estuary by GNI Group Ltd, KitosCell LP in Mexico. Pirfenidone suppliers market it in the form of oral capsules of 267 mg or oral tablets of 267 mg or 801 mg. In Mexico, Pirfenidone can be found under a topical form created for the treatment of abnormal wound healing processes. Warnings: Follow all Instructions on your medicine package and label. It is wise to tell your healthcare providers about all your medical allergies, illnesses, and all medicines you use. Before taking PIRFENIDONE: You should not use This medical drug if you are allergic to it This drug may also be used for purposes that may not have been listed in this medication guide. Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified rosiglitazone manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform.

How does PIRFENIDONE work?

The usage of this pharmaceutical substance: Read the Guide and, if available, the Patient Information Leaflet that will be provided by your pharmacist before you start taking PIRFENIDONE. If you have any questions related to this medical remedy, ask your pharmacist or doctor. To treat Idiopathic Pulmonary Fibrosis, an adult patient should take the initial dose of 267 mg oral capsule three a day from day one to day seven. From day eight today fourteen, the patient should take 534 mg of Pirfenidone three times a day. At the maintenance stage, the dose should not exceed 801 mg of Pirfenidone three times a day on day fifteen. During the treatment, Pirfenidone should be taken with food; it helps reduce nausea and dizziness. Taking Pirfenidone can cause some side effects, some of them include diarrhea, itching or skin rash, nausea, redness or other discoloration of the skin, severe sunburn, stomach discomfort, upset, or pain, vomiting. Take this pharmaceutical product by mouth with food as directed by your doctor, normally 3 times a day. Taking this medical drug with food may help minimize nausea and dizziness.

The Wholesale Price of PIRFENIDONE?

It is obtainable in generic and brand versions. It is not covered by most Medicare and insurance plans, but pharmacy coupons can help balance the price. In the US, under the brand name Esbriet, a 267 mg capsule and a 267 mg tablet cost about $38.12. An 801 mg oral tablet of Esbriet costs about $114.36. In the Pipelinepharma pharmaceutical marketplace, Pirfenidone is most available from the EU, Turkey, India, Argentina, and Guatemala. Prices may vary on the pharmacy you visit.

Sourcing the PIRFENIDONE Manufacturers and Suppliers

If you are looking to find manufacturers and suppliers of PIRFENIDONE, locate them quickly using Pipelinepharma's online marketplace. With this convenient B2B platform, you can order types of medications and quantities you require from companies that have passed our stringent vetting and quality control procedures. Being a global B2B pharmaceutical online marketplace, Pipelinepharma is structured to simplify pharmaceutical deals by providing you with an intuitive interface that is easy to engage with. The selection of PIRFENIDONE offerings can be narrowed down with the use of filters and easily weighed against one another according to medication prices and commercial terms. The advanced filters help you filter out the countries for this substance manufacturer and these substance suppliers that you are looking for. These also enable you to check the dossier status of this medicine, and the GMP approvals of the different variants of PIRFENIDONE. Also, each manufacturer or supplier product description contains essential information about this substance including clinical data, stability zones, countries where PIRFENIDONE is already registered in. Manufacturers also have special, and delivery terms.

Establishing commercial ties

If you are a pharmaceutical licensing company or a distributor you can enter into deals or negotiations over these medicine offers with manufacturing companies after completing the free registration process and joining our online marketplace. This helps to ensure that you conclude the pharmaceutical deal at a reasonable cost and achieve the best cost/benefit ratio for your company while bypassing lengthy sourcing, negotiation, and ordering process. Once you have finalized a deal, you can look forward to a long-lasting business relationship with the manufacturers or suppliers. This way, the marketplace allows you as a distributor to skip the process of shortlisting product manufacturers every time you are looking for in-licensing or distribution deals.

Quality Assurance

To keep up to the quality standards other than Good Manufacturing Practice approvals that this medicine manufacturers list has, we qualify their companies before they are onboarded on the platform. This allows us to screen PIRFENIDONE manufacturers for the quality of the pharmaceutical products’ dossiers and protect against the risk of possible malpractices.